The latest news from oncology events around the world
Adjuvant treatment with the targeted therapy drug selpercatinib can help reduce the risk that cancer…
A digital symptom monitoring program supported by palliative care nurses helped maintain quality of life…
Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained…
The report “Lancet Oncology Commission on Cancer Workforce: A Global Crisis” was launched at the…
At the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) Andrew Wagner (Dana-Farber Cancer…
At the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) David Reardon, MD, director…
Real-world data shows that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related…
The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favourable safety…
Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with…
Cancer risk increases with age and is often more aggressive and difficult to treat in…